Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for generating and displaying outputs conditioned on inputs. One of the methods includes displaying an interactive spreadsheet on a display of a user device; receiving an input from a user that identifies one or more cells to be filled in with respective predicted values; in response to receiving the input: training a machine learning model on the values in the cells of the interactive spreadsheet to predict respective values for the one or more identified cells; generating a respective predicted value for each of the identified cells using the trained machine learning model; and displaying the respective predicted values on the user device.

Abstract: The invention relates to immunogenic compositions and vaccines containing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; also referred to as SARS-CoV-2)) protein or a polynucleotide encoding a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) protein and uses thereof. The invention also provides methods of treating and/or preventing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) infection by administering an immunogenic composition or vaccine to a subject (e.g., a human). The invention also provides methods of detecting and/or monitoring a protective anti-coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) antibody response (e.g., anti-coronavirus antibody response, e.g., anti-2019-nCoV antibody response, e.g., anti-Spike antibody response, e.g., anti-Spike neutralizing antibody response).

Abstract: The invention relates to immunogenic compositions and vaccines containing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; also referred to as SARS-CoV-2)) protein or a polynucleotide encoding a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) protein and uses thereof. The invention also provides methods of treating and/or preventing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) infection by administering an immunogenic composition or vaccine to a subject (e.g., a human). The invention also provides methods of detecting and/or monitoring a protective anti-coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) antibody response (e.g., anti-coronavirus antibody response, e.g., anti-2019-nCoV antibody response, e.g., anti-Spike antibody response, e.g., anti-Spike neutralizing antibody response).

Abstract: The invention relates to immunogenic compositions and vaccines containing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; also referred to as SARS-CoV-2)) protein or a polynucleotide encoding a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) protein and uses thereof. The invention also provides methods of treating and/or preventing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) infection by administering an immunogenic composition or vaccine to a subject (e.g., a human). The invention also provides methods of detecting and/or monitoring a protective anti-coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) antibody response (e.g., anti-coronavirus antibody response, e.g., anti-2019-nCoV antibody response, e.g., anti-Spike antibody response, e.g., anti-Spike neutralizing antibody response).

Abstract: The invention relates to immunogenic compositions and vaccines containing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; also referred to as SARS-CoV-2)) protein or a polynucleotide encoding a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) protein and uses thereof. The invention also provides methods of treating and/or preventing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) infection by administering an immunogenic composition or vaccine to a subject (e.g., a human). The invention also provides methods of detecting and/or monitoring a protective anti-coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) antibody response (e.g., anti-coronavirus antibody response, e.g., anti-2019-nCoV antibody response, e.g., anti-Spike antibody response, e.g., anti-Spike neutralizing antibody response).

Abstract: The invention relates to immunogenic compositions and vaccines containing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; also referred to as SARS-CoV-2)) protein or a polynucleotide encoding a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) protein and uses thereof. The invention also provides methods of treating and/or preventing a coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) infection by administering an immunogenic composition or vaccine to a subject (e.g., a human). The invention also provides methods of detecting and/or monitoring a protective anti-coronavirus (e.g., Wuhan coronavirus (2019-nCoV; SARS-CoV-2)) antibody response (e.g., anti-coronavirus antibody response, e.g., anti-2019-nCoV antibody response, e.g., anti-Spike antibody response, e.g., anti-Spike neutralizing antibody response).

Abstract: A digital audio system configured to facilitate a collaborative audio session comprises a first digital audio device operable by a first user, a second digital audio device operable by a second user independently of the first digital audio device, and a server configured to communicate with the first digital audio device and the second digital audio device over a network, receive a request from at least one of the digital audio devices for participation in a collaborative audio session, and facilitate communication between the first digital audio device and the second digital audio device.

Abstract: The invention relates to an anchor piece for fixing an intervertebral implant (15) to the end plate of a vertebra body (19;20), comprising A) an anchor piece (1), with a central axis (6) and two end faces (4, 5) transverse to the central axis (6), B) at least two spikes (7) extending from one of the end faces (4;5), parallel to the central axis (6) and which may be pushed into an end plate of a vertebral body (19;20), whereby B) the anchor piece (1) has a cavity (3) extending through the anchor piece (1) in the direction of the central axis (6) and C) the anchor piece (1) comprises fixing means (9), by means of which the anchor piece may be detachably locked to an intervertebral implant (15).

Abstract: The invention relates to an anchor piece for fixing an intervertebral implant (15) to the end plate of a vertebra body (19;20), comprising A) an anchor piece (1), with a central axis (6) and two end faces (4, 5) transverse to the central axis (6), B) at least two spikes (7) extending from one of the end faces (4;5), parallel to the central axis (6) and which may be pushed into an end plate of a vertebral body (19;20), whereby B) the anchor piece (1) has a cavity (3) extending through the anchor piece (1) in the direction of the central axis (6) and C) the anchor piece (1) comprises fixing means (9), by means of which the anchor piece may be detachably locked to an intervertebral implant (15).

Abstract: An exemplary apparatus for providing VoIP services comprises: (a) a telephone hardware interface connectable to a POTS network; (b) a VoIP gateway connectable to a VoIP network; (c) a bridge operable to interconnect a POTS session over the telephone hardware interface with a VoIP session over the VoIP gateway; and (d) an input/output interface that is connected to at least one of the telephone hardware interface, the VoIP gateway, and the bridge, and which is also connectable to a telephone.

Abstract: A digital audio system configured to facilitate a collaborative audio session comprises a first digital audio device operable by a first user, a second digital audio device operable by a second user independently of the first digital audio device, and a server configured to communicate with the first digital audio device and the second digital audio device over a network, receive a request from at least one of the digital audio devices for participation in a collaborative audio session, and facilitate communication between the first digital audio device and the second digital audio device.